Approval · Notice of Compliance 1512 · 2000
PMS-VANCOMYCIN: Notice of Compliance 1512
Issued March 14, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1512
- Date
- March 14, 2000
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- VANCOCIN (Eli Lilly And Company)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-VANCOMYCIN | 02241820 | Dormant |
| PMS-VANCOMYCIN | 02241821 | Dormant |
Medicinal ingredients
- VANCOMYCIN HYDROCHLORIDE 0.5 G per VIAL
- VANCOMYCIN HYDROCHLORIDE 1 G per VIAL